Experimental cell therapy takes on relapsed leukemia
Disease control
Terminated
This study tested a new treatment called TCB008 for adults with acute myeloid leukemia (AML) that did not respond to standard therapy or came back after treatment. TCB008 uses specially grown immune cells from healthy donors to attack the cancer. The trial aimed to see if this th…
Phase: PHASE2 • Sponsor: TC Biopharm • Aim: Disease control
Last updated May 17, 2026 05:35 UTC